3D Global Biotech Inc. (TPEX: 6808)

3D Global Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,744	1,088	1,498	2,143	2,645	-
Market Cap Growth	64.82%	-27.35%	-30.09%	-18.98%	-	-
Enterprise Value	3,410	915	1,295	1,901	2,368	-
Last Close Price	48.75	19.19	26.58	39.16	48.33	-
PS Ratio	53.02	52.74	109.79	193.46	199.42	-
PB Ratio	7.13	3.71	4.40	5.50	5.89	-
P/TBV Ratio	7.23	5.69	6.70	9.03	9.44	-
EV/Sales Ratio	61.83	44.33	94.89	171.68	178.57	-
Debt / Equity Ratio	0.02	0.04	0.05	0.05	0.05	0.01
Asset Turnover	0.13	0.06	0.03	0.02	0.03	0.04
Inventory Turnover	0.86	4.41	5.14	9.16	7.15	-
Quick Ratio	5.98	6.34	10.41	15.71	23.46	27.82
Current Ratio	6.79	6.63	10.71	16.04	23.64	28.02
Return on Equity (ROE)	-7.64%	-18.28%	-18.37%	-14.24%	-10.22%	-8.22%
Return on Assets (ROA)	-5.11%	-11.30%	-10.41%	-8.57%	-6.36%	-4.97%
Return on Capital (ROIC)	-5.54%	-11.88%	-10.78%	-8.83%	-6.54%	-5.08%
Earnings Yield	-1.01%	-5.33%	-4.48%	-2.79%	-1.81%	-
FCF Yield	-0.36%	-2.98%	-2.36%	-1.81%	-0.88%	-
Buyback Yield / Dilution	-7.54%	-2.32%	-1.69%	-0.77%	-6.02%	-1.03%
Total Shareholder Return	-7.54%	-2.32%	-1.69%	-0.77%	-6.02%	-1.03%

Source: S&P Capital IQ. Standard template. Financial Sources.